HQ: Novato, California, United States

Ultragenyx Pharmaceutical Contact Information – Key Personnel, Emails & Support Lines

ultragenyx.com

About Ultragenyx Pharmaceutical Company

Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.

Ultragenyx Pharmaceutical Specialization

Biotechnology, Healthcare & Medical, Pharmaceuticals

Ultragenyx Pharmaceutical General Information

HQ: Novato, California, United States

Business Type: Public

Employees: 501-1000

Rounds: Post-IPO Equity

Founded Date: 2010

Number of Exits: 1

Company Type: For Profit

Stock Symbol: NASDAQ:RARE

Operating Status: Active

Last Funding Type: Post-IPO Equity

Phone Number: +1 415 483 8800

Last Investment Activity: Feb 26, 2024

Investments Activity: Feb 26, 2024 Jan 9, 2024 Nov 3, 2023

Ultragenyx Pharmaceutical Email Format

{first_letter_first_name}{last_name}@ultragenyx.com — 83.3% (example: ssmith@domain.com)

{first_name}@ultragenyx.com — 16.7% (example: sarah@domain.com)

Ultragenyx Pharmaceutical General Ultragenyx Pharmaceutical Emails

  • General Inquiries

    info@ultragenyx.com

  • Unclassified inbox

    trialrecruitment@ultragenyx.com

  • Unclassified inbox

    MCorley@ultragenyx.com

  • Investor Relations

    higair@ultragenyx.com

  • Media Relations

    blakemedia@ultragenyx.com

  • Unclassified inbox

    ekakkis@ultragenyx.com

  • Unclassified inbox

    gcapiaux@ultragenyx.com

Contact details of 10 Ultragenyx Pharmaceutical executives

John Klock

Founder
  • Work email

    j**n@ultragenyx.com

Jung Cho

Associate Director of Validation
  • Work email

    j**o@ultragenyx.com

Akhilesh Bhambhani

Sr. Director, Biologics Drug Product Development- Tech Dev/Tech Ops
  • Work email

    a********i@ultragenyx.com

Marisa Capponi

Associate Director
  • Work email

    m******i@ultragenyx.com

Benjamin Ehrhart

Vice President, Assistant General Counsel
  • Work email

    b******t@ultragenyx.com

Kenneth Lowe

Director

Howard Horn

Executive Vice President and CFO

John Pinion

EVP Translational Sciences, Chief Quality Operations Officer

Dennis Huang

Chief Technical Operations Officer; EVP Gene Therapy Operations

Emil D. Kakkis

Founder

Contact details of 4 Ultragenyx Pharmaceutical other employees

Xiaohui Lu

Senior Research Scientist
  • Work email

    x*u@ultragenyx.com

Yael Weiss

VP Business Development,Executive Director, Search and Evaluation, Business Development

Christine Murray

Senior Advisor, Development

Carolyn Wang

SVP, Global Corporate Communications

Similar Companies like Ultragenyx Pharmaceutical

HQ: North Chicago, Illinois, United States

AbbVie

abbvie.com

AbbVie is a pharmaceutical company that discovers, develops,...

HQ: North Chicago, Illinois, United States

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Debt

Last Investment Activity: Mar 22, 2024

Founded Date: 2013

Number of Exits: 3

Company Type: For Profit

Stock Symbol: NYSE:ABBV

Operating Status: Active

HQ: Minneapolis, Minnesota, United States

Medtronic

medtronic.com

Medtronic develops healthcare technology solutions for vario...

HQ: Minneapolis, Minnesota, United States

Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics Medical Devices Hospitals & Clinics

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Debt

Last Investment Activity: Mar 27, 2024

Founded Date: 1949

Number of Exits: 28

Company Type: For Profit

Stock Symbol: NYSE:MDT

Operating Status: Active

HQ: New York, New York, United States

Pfizer is a biopharmaceutical company that provides affordab...

HQ: New York, New York, United States

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Debt

Last Investment Activity: Sep 3, 2024

Venture Stage: Early Stage Venture, Late Stage Venture, Post-Ipo, Private Equity, Seed, Venture

Founded Date: 1849

Number of Exits: 19

Company Type: For Profit

Stock Symbol: NYSE:PFE

Operating Status: Active

Investor Type: Corporate Venture Capital, Venture Capital


Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.